TP53 and glioblastoma: In 45 patients with IDH wild-type glioblastoma, age at diagnosis, gender, tumour site, maximum tumour diameter, degree of tumour resection, KPS score, postoperative radiotherapy with simultaneous temozolomide chemotherapy, TMT, MGMT, and TP53 were included in the univariate analysis.